Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

PediSEP1 · Risk stratified care to reduce antibiotic use and AMR transmission in African hospitals

HORIZONStatus: SIGNED1 July 202530 June 2030EU funding €5,998,993Call HORIZON-JU-GH-EDCTP3-2024-01-two-stage

In suv-Saharan Africa (sSA), most government-run hospitals aim to follow WHO or national syndrome-based guidelines. Clinical syndromes, such as ‘severe pneumonia’ are designed to be sensitive for pathologies like invasive bacterial disease that require specific treatments to prevent death. However, low specificity means that a far wider group of children is captured by a syndrome definition including many with a self-limiting infection and very low risk of death. Currently, decisions regarding admission, discharge, and escalating or de-escalating antimicrobials are typically made by staff with limited paediatric training, very often interns, and current guidelines have very limited or no advice on de-escalation and discharge. These factors contribute to antimicrobial over-use, overly broad-spectrum prescribing, and unnecessarily prolonged treatment ‘to be on the safe side’. Excessive duration of antibiotic treatment means a greater risk of acquiring AMR from the hospital environment, significant costs to health providers and families, overcrowding, a low nurse:patient ratio, and reduced care for higher risk children.We propose that major reductions in antibiotic use, exposure to the hospital environment and transmission of AMR can be achieved by risk stratified care enabling very low-risk children admitted to hospital to be cohorted away from longer-stay patients, stop antibiotics and go home earlier with inexpensive phone follow up. We will engage policymakers, undertake mathematical modelling of antimicrobial usage, AMR transmission and costs across sSA within risk strataand conduct a trial of risk stratified care, and develop a tool 'PPS-plus' for monitoring of AMR transmission through simple cross sectional surveys.Relevance to the work programme includes combatting the major global threat from AMR through identification of personalised treatment options, a better evidence-base for policymaking, and digital tools to optimise clinical workflows.

Consortium · 10 organisations

coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

UK · €553,811

participant

HEALTH RESEARCH OPERATIONS KENYA LIMITED

KE · €3,191,570

associatedPartner

UNIVERSITY OF BRITISH COLUMBIA

CA

associatedPartner

UNIVERSITY OF WASHINGTON

US

participant

FONDAZIONE PENTA ETS

IT · €199,896

participant

TRAINING & RESEARCH UNIT OF EXCELLENCE LIMITED

MW · €599,940

associatedPartner

JOHNS HOPKINS UNIVERSITY

US

participant

UNIVERSITY COLLEGE LONDON

UK · €267,975

participant

WORLD ALLIANCE FOR LUNG AND INTENSIVE CARE MEDICINE IN UGANDA (WALIMU)

UG · €671,440

participant

KENYA MEDICAL RESEARCH INSTITUTE

KE · €514,360

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.